Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Journal of Neuroimmunology|November 21, 2017
Neurodegenerative diseases: The immunological perspectiveMonica Molteni, Carlo RossettiMediators of Inflammation|June 14, 2016
The Role of Toll-Like Receptor 4 in Infectious and Noninfectious InflammationMonica Molteni, Sabrina Gemma, Carlo RossettiToxins|July 18, 2018
The Effect of Cyanobacterial LPS Antagonist (CyP) on Cytokines and Micro-RNA Expression Induced by <i>Porphyromonas gingivalis</i> LPSMonica Molteni, Annalisa Bosi, Carlo RossettiInternational Journal of Inflammation|April 25, 2018
Natural Products with Toll-Like Receptor 4 Antagonist ActivityMonica Molteni, Annalisa Bosi, Carlo RossettiCancer Letters|June 1, 2005
Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4Monica Molteni, Deborah Marabella, Chiara Orlandi, et al.Scientific Reports|July 29, 2018
MiR-146a induction by cyanobacterial lipopolysaccharide antagonist (CyP) mediates endotoxin cross-toleranceMonica Molteni, Annalisa Bosi, Vincenzo Saturni, et al.Infection and Immunity|April 30, 2008
A cyanobacterial lipopolysaccharide antagonist inhibits cytokine production induced by Neisseria meningitidis in a human whole-blood model of septicemiaKim Jemmett, Annalisa Macagno, Monica Molteni, et al.Cancer Detection and Prevention|June 6, 2003
Regulatory CD8+ T cells control thyrotropin receptor-specific CD4+ clones in healthy subjectsMonica Molteni, Carlo Rossetti, Santo Scrofani, et al.Immunology Letters|June 18, 2002
Co-expression of the CD8 receptor in a human CD4+ T-cell clone influences proliferation, cytosolic Ca2+ release and cytokine productionMonica Molteni, Leonard D Kohn, Carlo Rossetti, et al.International Immunopharmacology|December 1, 2010
Effect of the lipopolysaccharide antagonist Planktothrix sp. FP1 cyanobacterial extract on human polymorphonuclear leukocytesRamòna Consuèlo Maio, Marco Cosentino, Carlo Rossetti, et al.Pageof 5